Does Ozempic Cause Hair Loss?
Should people be concerned about possible hair loss when taking Wegovy, Ozempic, or Mounjaro for weight loss (where the latter two drugs are being used off label) — as was recently claimed by some people on social media and reported in news stories?
The consensus among dermatologists and endocrinologists contacted by Medscape is no. It’s up to the individual to weigh the benefits of treating obesity against the risks of the therapy, including the low risk of developing temporary hair loss, says one expert.
Wegovy, Ozempic, and Mounjaro: Of these three newer medications, only the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy) is approved by the US Food and Drug Administration (since June 2021) for weight management — specifically for people with either obesity (body mass index [BMI] ≥ 30) or overweight (BMI ≥ 27) plus at least one weight-related comorbidity such as hypertension, type 2 diabetes, and high cholesterol — with a dosage up to a 2.4-mg weekly injection.
Excerpted from Medscape
